Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 310, Issue 10, Pages E811-E820
Publisher
American Physiological Society
Online
2016-04-07
DOI
10.1152/ajpendo.00049.2016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
- (2016) Kyunghee Lee et al. International Journal of Biological Sciences
- Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy
- (2016) Sung-Hee Yoon et al. NEUROMUSCULAR DISORDERS
- Effect of Bisphosphonates on the Rapidly Growing Male Murine Skeleton
- (2014) Eric D. Zhu et al. ENDOCRINOLOGY
- Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in post-menopausal women
- (2014) H. Uemura et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage
- (2013) Ariana dela Cruz et al. BONE
- Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL
- (2013) N C Walsh et al. GENES AND IMMUNITY
- IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro
- (2013) Shoichi Kaneshiro et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mutations Affecting G-Protein Subunit α11 in Hypercalcemia and Hypocalcemia
- (2013) M. Andrew Nesbit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors
- (2012) Preetinder P. Singh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
- (2012) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Pamidronate on Human Alveolar Osteoblasts In Vitro
- (2012) Darja Marolt et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Mineral Composition is Altered by Osteoblast Expression of an Engineered Gs-Coupled Receptor
- (2011) G. J. Kazakia et al. CALCIFIED TISSUE INTERNATIONAL
- A short account of metastatic bone disease
- (2011) Liviu Feller et al. Cancer Cell International
- Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta
- (2011) R. Bargman et al. OSTEOPOROSIS INTERNATIONAL
- M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
- (2011) Jason M. Hodge et al. PLoS One
- Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor
- (2010) Ling Guo et al. ARCHIVES OF ORAL BIOLOGY
- Cellular and Molecular Mechanisms of Bone Remodeling
- (2010) Liza J. Raggatt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized mice
- (2009) Gang-Qing Yao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis
- (2009) Sung Wook Seo et al. BONE
- Control of RANKL gene expression
- (2009) Charles A. O'Brien BONE
- Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro
- (2008) Aymen I. Idris et al. CALCIFIED TISSUE INTERNATIONAL
- Angiotensin II accelerates osteoporosis by activating osteoclasts
- (2008) Hideo Shimizu et al. FASEB JOURNAL
- Inhibition of osteoblast function in vitro by aminobisphosphonates
- (2008) Isabel R. Orriss et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass
- (2008) E. C. Hsiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism
- (2007) Inaam A. Nakchbandi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started